Fidelity SPDR Advertisement
Home > Boards > US OTC > Delisted > GTC Biotherapeutics (fka GTCB)

Re: Expiration dates of Rituxan patents

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 488
Posts 82,107
Boards Moderated 24
Alias Born 09/05/02
160x600 placeholder
U.S. Stocks Struggle To Rally In Choppy Trade
Trading action on Wall Street was mostly subdued on Tuesday, as investors reacted to a series of economic data, highlighted by a surprise dip in consumer confidence index.
Top Equities Stories Of The Day
Spotify's Revenue Rose in 2013, But Losses Continued - 2nd Update
Frontier Bond Sales Poised for Buoyant Year-End -- 2nd Update
Faith-Based Shareholders Prepare Day of Reckoning for Bank of America
Appeals Court Grants TV Programmers Stay in FCC Dispute -- Update
Carriers Issue Debt as Spectrum Auction Bids Top $36 Billion
Kinder Morgan Unveils $6 Billion Debt Offer -- Update
Correction to La Compagnie Fares Story
Activision Blizzard to Get $275 Million in Settlement
DewDiligence Member Level  Saturday, 03/15/08 06:12:36 PM
Re: masterlongevity post# 8871
Post # of 19307 
Re: Expiration dates of Rituxan patents

According to DNA itself, the US patents that protect Rituxan are 5,677,180 (“Chimeric antibody with specificity to human B cell surface antigen”) and 5,736,137 (“Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma”).

The ‘180’ patent expires in Oct 2014 and the ‘1378’ patent expires in Apr 2015.

GTC believes that only the ‘180’ patent is relevant to GTC’s CD20 mAb program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist